CLASS II Device recall · Reported 29 Apr 2020 · FDA Enforcement Report

Architect Havab G Reagent Kit recalled by Abbott Gmbh & Co. KG

Abbott Gmbh & Co. KG is recalling Architect Havab G Reagent Kit, distributed nationwide in the US. The recall was initiated on 9 Mar 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesList Number 6L27 25. Lot No: 03429BE00, 06172BE00, 08073BE00, 10353BE00. UDI: (01)00380740011185 (17)200320(10)03429BE00, (01)00380740011185 (17)200604(10)06172BE00, (01)00380740011185 (17)200819(10)08073BE00, (01)00380740011185 (17)201023(10)10353BE00.
Quantity recalled7,347 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1728-2020
FDA event ID
85238
Recalling firm
Abbott Gmbh & Co. KG, Wiesbaden, N/A
Classification
Class II
Status
Terminated
Recall initiated
9 Mar 2020
FDA classified
17 Apr 2020
Reported
29 Apr 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Hepatitis A

Timeline

9 Mar 2020Recall initiated by company
17 Apr 2020Classified by FDA+39 days
29 Apr 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

An erroneous concentration value for hepatitis A virus was utilized during manufacture, leading to a decreased amount of antigen used for the impacted lots.

Product as listed by the FDA

ARCHITECT HAVAB G Reagent Kit. List Number 6L27 25.

Where it was distributed

US nationwide including the states of AL, AR, AZ, CA, CO, CT DE, FL, GA, ID, IL, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, NH, NJ, NM NV, NY, OH, OK, OR, PA, RH, SC, TN, TZ, UT, VA, WA, WI, WV AND PR.

Nationwide AlabamaArkansasArizonaCaliforniaColoradoConnecticutFloridaGeorgiaIdahoIllinoisKansasKentuckyLouisianaMassachusettsMarylandMichiganMinnesotaMissouriMississippiNorth Carolina

Questions about this recall

Why was it recalled?

An erroneous concentration value for hepatitis A virus was utilized during manufacture, leading to a decreased amount of antigen used for the impacted lots.

Which lots are affected?

List Number 6L27 25. Lot No: 03429BE00, 06172BE00, 08073BE00, 10353BE00. UDI: (01)00380740011185 (17)200320(10)03429BE00, (01)00380740011185 (17)200604(10)06172BE00, (01)00380740011185 (17)200819(10)08073BE00, (01)00380740011185 (17)201023(10)10353BE00.

Where was it sold?

US nationwide including the states of AL, AR, AZ, CA, CO, CT DE, FL, GA, ID, IL, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, NH, NJ, NM NV, NY, OH, OK, OR, PA, RH, SC, TN, TZ, UT, VA, WA, WI, WV AND PR.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Abbott Gmbh & Co. KG

All 19

Other Test Kits & Diagnostics recalls

All 2,668